Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/09/2012 | EP1409506B1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
05/09/2012 | EP1379337B1 Generation of pharmaceutical agent particles using focused acoustic energy |
05/09/2012 | EP1372610B1 Powder inhaler formulations |
05/09/2012 | EP1284963B1 Novel calcium receptor active molecules and method for preparing same |
05/09/2012 | EP1276480B1 Levobupivacaine pharmaceutical compositions formulated on its free base form or its pharmaceutical acceptable salts and their use |
05/09/2012 | CN202211874U Compound simvastatin niacin double-release capsule |
05/09/2012 | CN202211185U Escape/rescue mask |
05/09/2012 | CN1978449B Method of purifying episesamin |
05/09/2012 | CN1946400B Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies |
05/09/2012 | CN1929838B Solid pharmaceutical preparation containing sparingly water-soluble drug |
05/09/2012 | CN1822844B Glycoside-containing liposome |
05/09/2012 | CN1809539B Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 |
05/09/2012 | CN1688586B Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors |
05/09/2012 | CN1636577B Vaginal care composition |
05/09/2012 | CN1596248B Phenoxy amine compounds and compositions for delivering active agents |
05/09/2012 | CN102449152A Polyion complex of double-stranded ribonucleic acid |
05/09/2012 | CN102449151A Methods for treating eye disorders |
05/09/2012 | CN102448978A Novel Glucocorticoid Receptor Agonists |
05/09/2012 | CN102448969A Inhibitors of C-MET protein kinase |
05/09/2012 | CN102448968A Substituted pyrazole inhibitors of c-met protein kinase |
05/09/2012 | CN102448962A Heterocyclic urea derivatives and methods of use thereof |
05/09/2012 | CN102448961A Dihydro) imidazoiso (5, 1-A) quinolines as fsh receptor agonists for the treatment of fertility disorders |
05/09/2012 | CN102448960A Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-carboxylic acid amides |
05/09/2012 | CN102448959A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
05/09/2012 | CN102448958A Pyrimddinyl and 1,3,5-triazinyl benzimtoazole sulfonamides and their use in cancer therapy |
05/09/2012 | CN102448957A Compounds as cannabinoid receptor ligands |
05/09/2012 | CN102448956A Hepatitis c virus inhibitors |
05/09/2012 | CN102448955A Amino pyrimidine anticancer compounds |
05/09/2012 | CN102448953A Pyrazole compound |
05/09/2012 | CN102448952A Antiviral compounds and uses thereof |
05/09/2012 | CN102448951A Therapeutic compositions and related methods of use |
05/09/2012 | CN102448949A Heterocyclic compound and hematopoietic stem cell amplifier |
05/09/2012 | CN102448943A 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation |
05/09/2012 | CN102448942A Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof |
05/09/2012 | CN102448941A Substituted isoquinoline derivative |
05/09/2012 | CN102448940A Pharmaceutical composition for treating or preventing glaucoma |
05/09/2012 | CN102448939A Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs |
05/09/2012 | CN102448938A Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors |
05/09/2012 | CN102448937A Aryl Substituted Carboxamide Derivatives As Calcium Or Sodium Channel Blockers |
05/09/2012 | CN102448936A Heterocyclic antiviral compounds |
05/09/2012 | CN102448934A Resolution of (+-)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate |
05/09/2012 | CN102448931A Radiolabeled fluorine derivatives of methionine |
05/09/2012 | CN102448930A Thiocolchicine derivatives, method of making and methods of use thereof |
05/09/2012 | CN102448928A Substituted Aminobutyric Derivatives as Neprilysin Inhibitors |
05/09/2012 | CN102448927A A process for dimethylation of active methylene groups |
05/09/2012 | CN102448920A Antiviral compounds and uses thereof |
05/09/2012 | CN102448548A Heterocyclic antiviral compounds |
05/09/2012 | CN102448499A Oral ibuprofen lysinate suspension |
05/09/2012 | CN102448496A Medicine composition having iodine and steroid and application to treatment of rhinitis |
05/09/2012 | CN102448495A Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder |
05/09/2012 | CN102448485A Immunogenic composition and uses thereof |
05/09/2012 | CN102448470A Controlled exotherm of cyanoacrylate formulations |
05/09/2012 | CN102448469A Polyal (ketone) drug conjugates comprising variable rate-releasing linkers |
05/09/2012 | CN102448468A Pharmaceutical composition for prevention or treatment of lifestyle-related disease, and food useful for prevention or treatment of lifestyle-related disease |
05/09/2012 | CN102448467A Methods for administration and formulations for the treatment of regional adipose tissue |
05/09/2012 | CN102448466A New therapeutical uses of inecalcitol |
05/09/2012 | CN102448465A Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains |
05/09/2012 | CN102448464A Improved glucocorticoid therapy |
05/09/2012 | CN102448463A Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders |
05/09/2012 | CN102448462A Heteroaryl compounds and uses thereof |
05/09/2012 | CN102448461A Therapeutic uses of quinazolinedione derivatives |
05/09/2012 | CN102448460A Active pharmaceutical ingredient adsorbed on solid support |
05/09/2012 | CN102448459A Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability |
05/09/2012 | CN102448458A Methods and compositions of treating a flaviviridae family viral infection |
05/09/2012 | CN102448457A Methods and compositions of treating a flaviviridae family viral infection |
05/09/2012 | CN102448456A Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors |
05/09/2012 | CN102448455A Use of flavonoids to increase the bioavailability of hesperetin |
05/09/2012 | CN102448454A Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent |
05/09/2012 | CN102448453A Use of PUFAS to treat nerve damage |
05/09/2012 | CN102448452A Dietary supplement comprising alpha keto acids for supporting diabetes therapy |
05/09/2012 | CN102448451A Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein |
05/09/2012 | CN102448450A Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
05/09/2012 | CN102448445A Orally disintegrating coated tablet |
05/09/2012 | CN102448444A Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof |
05/09/2012 | CN102448442A Treatment of tissue adhesion |
05/09/2012 | CN102448439A Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining |
05/09/2012 | CN102448438A Anti-influenza formulations and methods |
05/09/2012 | CN102448437A Compositions and methods for alleviating hyposalivation and for providing oral comfort |
05/09/2012 | CN102448421A A multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical |
05/09/2012 | CN102448332A Trehalulose-containing composition, its preparation and use |
05/09/2012 | CN102448330A Dispersion of phytosterols |
05/09/2012 | CN102448310A Improved synthesis of picoplatin |
05/09/2012 | CN102448309A Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders |
05/09/2012 | CN102448308A Compositions and methods for increasing telomerase activity |
05/09/2012 | CN102448306A Methods for preventing and/or treating degenerative disorders of the central nervous system |
05/09/2012 | CN102448303A Ketal esters of anhydropentitols and uses thereof |
05/09/2012 | CN102443613A Antrodia camphorata anti-cancer active substance and preparation method and application thereof |
05/09/2012 | CN102443151A PCL (Polycaprolactone)-Tween 80 copolymer as well as preparation method and application thereof |
05/09/2012 | CN102443077A Isostichopus badionotus fucosylated mucopolysaccharide and application thereof |
05/09/2012 | CN102443045A N-substituted phenyl-14 beta -(aminomethyl) triptodiolide derivative and preparation method and application thereof |
05/09/2012 | CN102443044A N-substituted ester-containing phenyl-14 Beta-aminomethyl epitriptolide derivatives, preparation method and use thereof |
05/09/2012 | CN102443043A N-substituted-14 beta -(aminomethyl) triptodiolide derivative and preparation method and application thereof |
05/09/2012 | CN102443042A N-substituted methoxy-containing phenyl-14 Beta-aminomethyl epitriptolide derivatives, preparation method and use thereof |
05/09/2012 | CN102443041A N-substituted methyl phenyl-14 beta -(aminomethyl) triptodiolide derivative and preparation method and application thereof |
05/09/2012 | CN102443040A N-substituted fluorinated phenyl-14 beta-(aminomethyl) triptodiolide derivative and preparation method and application thereof |
05/09/2012 | CN102443039A N-substituted amino phenyl-14 beta-(aminomethyl) triptodiolide derivative and preparation method and application thereof |
05/09/2012 | CN102443027A Fructose glycosylation puerarin, preparation method and application thereof |
05/09/2012 | CN102443026A Aminoglycoside compounds and extraction and separation method therefor |
05/09/2012 | CN102443015A 7-substituted quinoline carboxylic acid derivatives, preparation method and application thereof in antibiosis and antituberculosis |
05/09/2012 | CN102443009A Fused ring kinase inhibitor |